New study checks if jivi keeps joints healthy in hemophilia a patients
NCT ID NCT05643560
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This observational study tracks 33 adults with hemophilia A who choose to take Jivi, a longer-lasting clotting factor. Researchers use ultrasound to see if joint health improves or stays stable after 24 months of treatment. The goal is to understand how well Jivi works in everyday life to prevent joint problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Many Locations
Multiple Locations, Italy
Conditions
Explore the condition pages connected to this study.